TAGRISSO® (osimertinib) HCP

Explore TAGRISSO and how it may help your patients. Learn more at US only.
Click for Safety Info:

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@VickieBruni2 Hello Victoria, to learn more about TAGRISSO, please visit https://t.co/WnOWe22NC3.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

See if your patients are eligible for TAGRISSO.
US-62864 Last Updated 4/22

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@kc46girl Anytime! Please let us know if there's anything else we can help you with. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

Welcome to our page! Check out our community guidelines below to see what to expect from us on Twitter.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@kc46girl @kc46girl Thank you for bringing this issue to our attention. Please call one of our Patient Access Specialists at 1-844-ASK-A360 (1-844-275-2360) Monday through Friday from 8 AM to 8 PM ET and they can help connect you with the appropriate team member. We wish you the best.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@Boingatron Hi, @Boingatron AstraZeneca may be able to help. Please call one of our Patient Access Specialists at 1-844-ASK-A360 (1-844-275-2360). They’re available Monday through Friday from 8 AM to 8 PM ET and will be happy to assist you. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@redstopgringo Hi Danny, Twitter helps us deliver ads to people who may be interested. Although you can't opt out of seeing ads, you can hide ads and advertisers: https://t.co/v6fihE0Nor.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

Discover the new results from the ADAURA trial for TAGRISSO. US-67213 Last Updated 8/22

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@AgilEmpath Thank you for sharing your story, Priscilla. We're happy to hear that CALQUENCE has made a difference.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@AgilEmpath we appreciate you taking the time to share! Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@marinarapatriot Hi, Dr. Mari, to access helpful resources for you, please visit https://t.co/tL7UjQJedK. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

Are you sure you’ve seen all the data for TAGRISSO?
US-53319 Last Updated 5/21

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@rzstelling Great to hear! Would you be interested in sharing your story with others? If so, please call us at 917-774-7404.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

See why you should TEST and REFER every patient for the TAGRISSO opportunity.
US-56707 Last Updated 9/21

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@lizgrif11 For information about the cost of TAGRISSO, please contact one of our Patient Access Specialists at 1-844-ASK-A360 (1-844-275-2360). They're available Monday through Friday from 8 AM to 8 PM ET and will be happy to assist you. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@shasimss Gran, we now have information from a TAGRISSO clinical study about how long patients may live with treatment. Please visit https://t.co/kSAPFYS1gY for more information on this clinical study, as well as Important Safety Information.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

View full safety information at https://t.co/l9ph32fJgf
TAGRISSO is approved for metastatic EGFRm NSCLC.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@HippyChickaboo We appreciate your taking the time to share, Hippy Chick. Thank you for your comment. These are the kinds of messages we think could really inspire the community. Thank you again for sharing! We wish you well.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

View full safety information at https://t.co/pj6dR02yiK. TAGRISSO is approved for resectable EGFRm NSCLC.
Prioritize early testing for EGFR mutations.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@jdthatch1 We appreciate your taking the time to share, Jeff. We know this can be a very difficult time. Thank you so much for opening up to share your comment with us. We think his experience could help our community. We wish you well.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@jdthatch1 Thank you for your comment. We wish you the best!

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@lacjap Hi, @lacjap AstraZeneca may be able to help. Please call one of our Patient Access Specialists at 1-844-ASK-A360 (1-844-275-2360). They’re available Monday through Friday from 8 AM to 8 PM ET and will be happy to assist your patients. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

Have you seen the new data for TAGRISSO?
US-46287 Last Updated 11/20

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@ZekeStone7 Unfortunately, we aren’t able to comment in regard to specific cancers, medications or remedies. Your doctor is your best resource when it comes to your medical history and plans. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

See the TAGRISSO® (osimertinib) data your peers are talking about.

US-44159 Last Updated 8/20

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@tim_mcbreen @tim_mcbreen Unfortunately, we aren’t able to comment in regard to specific cancers, medications or remedies. Your doctor is your best resource when it comes to your medical history and plans. Be well.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

View the safety information at https://t.co/uuocHp3NiG
NOW APPROVED: TAGRISSO in resectable EGFRm NSCLC. Discover what adjuvant TAGRISSO may do for your patients.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@susila55 We are sorry to hear that. We would like to learn more about his experience. Please call us at 1-800- 236-9933. Take care.

[TAGRISSO® (osimertinib) HCP @TagrissoHCP]

@susila55 Thank you for your comment. We wish you the best.